{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":95,"description":"Oral testosterone undecanoate, LPCN 1021 225 mg TU two times a day.\n\nLPCN 1021: Oral testosterone undecanoate","id":"EG000","otherNumAffected":6,"otherNumAtRisk":95,"seriousNumAffected":1,"seriousNumAtRisk":95,"title":"Oral Testosterone Undecanoate, LPCN 1021"}],"frequencyThreshold":"1","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA (17.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":95,"numEvents":4}],"term":"Blood prolactin increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA (17.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":95,"numEvents":1}],"term":"Blood FSH decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA (17.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":95,"numEvents":1}],"term":"Blood LH decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (17.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":95,"numEvents":1}],"term":"PSA increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (17.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":95,"numEvents":1}],"term":"Weight increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (17.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":95,"numEvents":1}],"term":"Headache"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (17.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":95,"numEvents":1}],"term":"Gastric Ulcer Hemorrhage"}],"timeFrame":"1 month"}